Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus

Lung Cancer

Volumn 66, Issue 1, 2009, Pages 89-93

  Song, Si Yeol ^a   Choi, Wonsik ^a   Shin, Seong Soo ^a   Lee, Sang wook ^a   Ahn, Seung Do ^a   Kim, Jong Hoon ^a   Je, Hyoung Uk ^a   Park, Charn Il ^b   Lee, Jung Shin ^a   Choi, Eun Kyung ^a  

^a Asan Medical Center   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Bronchus; Central; Lung cancer; Pulmonary toxicity; Stereotactic body radiotherapy; Stricture

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHUS CANCER; BRONCHUS STENOSIS; CANCER CONTROL; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; BRONCHI; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOSURGERY; TREATMENT OUTCOME;

EID: 68949210483     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.12.016     Document Type: Article

References (33)

1. Martini N., and Beattie Jr. E.J. Results of surgical treatment in stage I lung cancer. J Thorac Cardiovasc Surg 74 (1977) 499-505
2. Mountain C.F. Assessment of the role of surgery for control of lung cancer. Ann Thorac Surg 24 (1977) 365-373
3. Martini N., Bains M.S., Burt M.E., Zakowski M.F., McCormack P., Rusch V.W., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109 (1995) 120-129
4. Lax I., Blomgren H., Naslund I., and Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33 (1994) 677-683
5. Dawson L.A., Brock K.K., Kazanjian S., Fitch D., McGinn C.J., Lawrence T.S., et al. The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 51 (2001) 1410-1421
6. Wilson E.M., Williams F.J., Lyn B.E., Wong J.W., and Aird E.G. Validation of active breathing control in patients with non-small-cell lung cancer to be treated with CHARTWEL. Int J Radiat Oncol Biol Phys 57 (2003) 864-874
7. Purdie T.G., Moseley D.J., Bissonnette J.P., Sharpe M.B., Franks K., Bezjak A., et al. Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in Stereotactic Lung Radiation Therapy. Acta Oncol 45 (2006) 915-922
8. Yue N.J., Li X., Beriwal S., Heron D.E., Sontag M.R., and Huq M.S. The intrafraction motion induced dosimetric impacts in breast 3D radiation treatment: a 4DCT based study. Med Phys 34 (2007) 2789-2800
9. Ricardi U., Guarneri A., Mantovani C., Ciammella P., Giglioli F.R., and Ragona R. Stereotactic body radiation therapy for early non-small cell lung cancer: experience at the University of Turin. J Thorac Oncol 2 (2007) S47
10. Onishi H., Shirato H., Nagata Y., Hiraoka M., Fujino M., Gomi K., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2 (2007) S94-100
11. Hof H., Muenter M., Oetzel D., Hoess A., Debus J., and Herfarth K. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 110 (2007) 148-155
12. Hiraoka M., Matsuo Y., and Nagata Y. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer. Cancer Radiother 11 (2007) 32-35
13. Hiraoka M., and Ishikura S. A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer. J Thorac Oncol 2 (2007) S115-117
14. Franks K.N., Bezjak A., Purdie T.G., Bissonnette J.P., Pearson S., Payne D., et al. Early results of image-guided radiation therapy in lung stereotactic body radiotherapy (SBRT). Clin Oncol (R Coll Radiol) 19 (2007) S10
15. Brown W.T., Wu X., Amendola B., Perman M., Han H., Fayad F., et al. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation-CyberKnife. Cancer J 13 (2007) 87-94
16. Ball D., and Withers H.R. Stereotactic radiotherapy for stage I non-small-cell lung cancer-the triumph of technology over biology?. Nat Clin Pract Oncol (2007)
17. Zimmermann F.B., Geinitz H., Schill S., Thamm R., Nieder C., Schratzenstaller U., et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 45 (2006) 796-801
18. Timmerman R., McGarry R., Yiannoutsos C., Papiez L., Tudor K., DeLuca J., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
19. Nyman J., Johansson K.A., and Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer 51 (2006) 97-103
20. Joyner M., Salter B.J., Papanikolaou N., and Fuss M. Stereotactic body radiation therapy for centrally located lung lesions. Acta Oncol 45 (2006) 802-807
21. Hara R., Itami J., Kondo T., Aruga T., Uno T., Sasano N., et al. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer 106 (2006) 1347-1352
22. Fritz P., Kraus H.J., Muhlnickel W., Hammer U., Dolken W., Engel-Riedel W., et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol 1 (2006) 30
23. Song D.Y., Benedict S.H., Cardinale R.M., Chung T.D., Chang M.G., and Schmidt-Ullrich R.K. Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits. Am J Clin Oncol 28 (2005) 591-596
24. McGarry R.C., Papiez L., Williams M., Whitford T., and Timmerman R.D. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 63 (2005) 1010-1015
25. Onishi H., Araki T., Shirato H., Nagata Y., Hiraoka M., Gomi K., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
26. Whyte R.I., Crownover R., Murphy M.J., Martin D.P., Rice T.W., DeCamp Jr. M.M., et al. Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thorac Surg 75 (2003) 1097-1101
27. Lee S.W., Choi E.K., Park H.J., Ahn S.D., Kim J.H., Kim K.J., et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 40 (2003) 309-315
28. Hof H., Herfarth K.K., Munter M., Hoess A., Motsch J., Wannenmacher M., et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56 (2003) 335-341
29. Wahlers B., Debus J., Droge S., Brendle B., and Freitag L. High-dose, stereotactic, one-time radiotherapy with curative intent for peripheral lung cancer. Pneumologie 54 (2000) 486-488
30. Uematsu M., Shioda A., Tahara K., Fukui T., Yamamoto F., Tsumatori G., et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 82 (1998) 1062-1070
31. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
32. James K., Eisenhauer E., Christian M., Terenziani M., Vena D., Muldal A., et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 91 (1999) 523-528
33. Yamashita H., Nakagawa K., Nakamura N., Koyanagi H., Tago M., Igaki H., et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2 (2007) 21